1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis

Evidence summary [ES29] Published: 21 July 2020

  • Advice
  • Tools and resources
  • Evidence

Evidence

Review and download supporting evidence.

Supporting evidence

  • Evidence review  
  • Evidence review PDF 281 KB 21 July 2020